BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36658582)

  • 1. Pancreatic stellate cell-induced gemcitabine resistance in pancreatic cancer is associated with LDHA- and MCT4-mediated enhanced glycolysis.
    Amrutkar M; Berg K; Balto A; Skilbrei MG; Finstadsveen AV; Aasrum M; Gladhaug IP; Verbeke CS
    Cancer Cell Int; 2023 Jan; 23(1):9. PubMed ID: 36658582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secretion of fibronectin by human pancreatic stellate cells promotes chemoresistance to gemcitabine in pancreatic cancer cells.
    Amrutkar M; Aasrum M; Verbeke CS; Gladhaug IP
    BMC Cancer; 2019 Jun; 19(1):596. PubMed ID: 31208372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paracrine HGF promotes EMT and mediates the effects of PSC on chemoresistance by activating c-Met/PI3K/Akt signaling in pancreatic cancer in vitro.
    Xu J; Liu S; Yang X; Cao S; Zhou Y
    Life Sci; 2020 Dec; 263():118523. PubMed ID: 33039386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paracrine SDF-1α signaling mediates the effects of PSCs on GEM chemoresistance through an IL-6 autocrine loop in pancreatic cancer cells.
    Zhang H; Wu H; Guan J; Wang L; Ren X; Shi X; Liang Z; Liu T
    Oncotarget; 2015 Feb; 6(5):3085-97. PubMed ID: 25609203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCL12 secreted by pancreatic stellate cells accelerates gemcitabine resistance of pancreatic cancer by enhancing glycolytic reprogramming.
    Lu X; Wu Y; Cao R; Yu X; Gong J
    Anim Cells Syst (Seoul); 2022; 26(4):148-157. PubMed ID: 36046033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TIMP1 down-regulation enhances gemcitabine sensitivity and reverses chemoresistance in pancreatic cancer.
    Tan Y; Li X; Tian Z; Chen S; Zou J; Lian G; Chen S; Huang K; Chen Y
    Biochem Pharmacol; 2021 Jul; 189():114085. PubMed ID: 32522594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential Gemcitabine Sensitivity in Primary Human Pancreatic Cancer Cells and Paired Stellate Cells Is Driven by Heterogenous Drug Uptake and Processing.
    Amrutkar M; Vethe NT; Verbeke CS; Aasrum M; Finstadsveen AV; Sántha P; Gladhaug IP
    Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33287390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins abrogate gemcitabine-induced PD-L1 expression in pancreatic cancer-associated fibroblasts and cancer cells with improved therapeutic outcome.
    Minz AP; Mohapatra D; Dutta M; Sethi M; Parida D; Mohapatra AP; Mishra S; Kar S; Sasmal PK; Senapati S
    Cancer Immunol Immunother; 2023 Dec; 72(12):4261-4278. PubMed ID: 37926727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The histone methyltransferase G9a as a therapeutic target to override gemcitabine resistance in pancreatic cancer.
    Pan MR; Hsu MC; Luo CW; Chen LT; Shan YS; Hung WC
    Oncotarget; 2016 Sep; 7(38):61136-61151. PubMed ID: 27531902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conditioned media of pancreatic cancer cells and pancreatic stellate cells induce myeloid-derived suppressor cells differentiation and lymphocytes suppression.
    Chong YP; Peter EP; Lee FJM; Chan CM; Chai S; Ling LPC; Tan EL; Ng SH; Masamune A; Ghafar SAA; Ismail N; Ho KL
    Sci Rep; 2022 Jul; 12(1):12315. PubMed ID: 35853996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive feedback in Cav-1-ROS signalling in PSCs mediates metabolic coupling between PSCs and tumour cells.
    Shao S; Qin T; Qian W; Yue Y; Xiao Y; Li X; Zhang D; Wang Z; Ma Q; Lei J
    J Cell Mol Med; 2020 Aug; 24(16):9397-9408. PubMed ID: 32633891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and Characterization of Paired Primary Cultures of Human Pancreatic Cancer Cells and Stellate Cells Derived from the Same Tumor.
    Amrutkar M; Larsen EK; Aasrum M; Finstadsveen AV; Andresen PA; Verbeke CS; Gladhaug IP
    Cells; 2020 Jan; 9(1):. PubMed ID: 31963309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular context-dependent interaction between cancer and stellate cells in hetero-type multicellular spheroids of pancreatic tumor.
    Nam S; Khawar IA; Park JK; Chang S; Kuh HJ
    Biochem Biophys Res Commun; 2019 Jul; 515(1):183-189. PubMed ID: 31133378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic stellate cell secreted IL-6 stimulates STAT3 dependent invasiveness of pancreatic intraepithelial neoplasia and cancer cells.
    Nagathihalli NS; Castellanos JA; VanSaun MN; Dai X; Ambrose M; Guo Q; Xiong Y; Merchant NB
    Oncotarget; 2016 Oct; 7(40):65982-65992. PubMed ID: 27602757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble factors from stellate cells induce pancreatic cancer cell proliferation via Nrf2-activated metabolic reprogramming and ROS detoxification.
    Wu YS; Looi CY; Subramaniam KS; Masamune A; Chung I
    Oncotarget; 2016 Jun; 7(24):36719-36732. PubMed ID: 27167341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidrug resistance genes screening of pancreatic ductal adenocarcinoma based on sensitivity profile to chemotherapeutic drugs.
    Zhao B; Qin C; Li Z; Wang Y; Li T; Cao H; Yang X; Li T; Wang W
    Cancer Cell Int; 2022 Dec; 22(1):374. PubMed ID: 36457017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pirfenidone inhibits pancreatic cancer desmoplasia by regulating stellate cells.
    Kozono S; Ohuchida K; Eguchi D; Ikenaga N; Fujiwara K; Cui L; Mizumoto K; Tanaka M
    Cancer Res; 2013 Apr; 73(7):2345-56. PubMed ID: 23348422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of ERK1/2 in cancer-associated pancreatic stellate cells suppresses cancer-stromal interaction and metastasis.
    Yan Z; Ohuchida K; Fei S; Zheng B; Guan W; Feng H; Kibe S; Ando Y; Koikawa K; Abe T; Iwamoto C; Shindo K; Moriyama T; Nakata K; Miyasaka Y; Ohtsuka T; Mizumoto K; Hashizume M; Nakamura M
    J Exp Clin Cancer Res; 2019 May; 38(1):221. PubMed ID: 31133044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of proliferation by omega-3 fatty acids in chemoresistant pancreatic cancer cells.
    Hering J; Garrean S; Dekoj TR; Razzak A; Saied A; Trevino J; Babcock TA; Espat NJ
    Ann Surg Oncol; 2007 Dec; 14(12):3620-8. PubMed ID: 17896154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gemcitabine Resistance in Pancreatic Ductal Carcinoma Cell Lines Stems from Reprogramming of Energy Metabolism.
    Fujiwara-Tani R; Sasaki T; Takagi T; Mori S; Kishi S; Nishiguchi Y; Ohmori H; Fujii K; Kuniyasu H
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.